Treatment of endometrial hyperplasia is formulated in relation to the patient’s age, the presence or absence of fertility requirements, and the extent of the lesion. Usually, the physician performs endometrial scraping to clarify the diagnosis, and the scraped endometrium is examined pathologically. The pathology of hyperplastic endometrium includes simple hyperplasia, complex hyperplasia, and atypical hyperplasia. The first two cases have no cellular heterogeneity, while the latter are precancerous lesions with a tendency to develop into endometrial cancer. After understanding the pathology of endometrial hyperplasia of patients, targeted treatment can be given to patients. For young patients with fertility requirements, endometrial hyperplasia without Atypia can be treated medically, usually by applying progestin to transform the hyperplastic endometrium into a secretory phase, and then the endometrium is shed after stopping the medication and withdrawal bleeding occurs, which is called “pharmacological scraping”. The treatment can then be combined with menstrual cycle adjustment and ovulation promotion. For older women without fertility requirements, especially those before and after menopause, histopathology of the endometrium suggests atypical hyperplasia, i.e. precancerous lesions, hysterectomy is preferred. For the treatment of endometrial hyperplasia, the endometrial pathology is very important. Those without atypical hyperplasia can be treated by medication; those with atypical hyperplasia and without fertility requirements prefer surgery.